Investors in Health

Calm/Storm Ventures is a founder network and boutique venture capital firm that invests in solutions improving health and wellbeing. They invest in founders that change lives for the better. Calm/Storm Ventures believe in lifelong learning and personal growth, empowering entrepreneurs with unique access to successful founders.

Public VC, fostering the Start-Up Ecosystem in Rhineland-Palatinate; Germany. Looking for early stage ventures with strong innovative technical aproach, skilful founderteam and scaleable marketpotential. Investing equity or equity-like up to 500 k€ initially.

Hummingbird Ventures is a global early stage venture capital fund backing outlier founders. They are global seed investors, looking for outlier founders. Hummingbird believes groundbreaking companies are built by a rare breed of entrepreneur.

imec.xpand is an independent global venture capital fund that focuses on transformative semiconductor and nanotechnology innovations where imec contributions can have a determining impact on the success of their technology development.

Investment is about building the future that lies ahead. Their investment opportunities are focused on AI because it drives the future of how machines, data, and technologies are being programmed. By channeling their deep domain expertise into identifying investment opportunities, they back AI companies with high potential to impact conventional industries or society.

Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds, with a focus on innovative companies that use technology as a competitive advantage.

They are a team of HealthTech entrepreneurs turned VC professionals who have founded laboratory groups, software companies, and tech companies. Now, they are looking to guide the next generation of HealthTech ventures.

Bioqube Ventures is a specialist life sciences investment firm based in Europe with a global footprint. They source, finance, and develop innovative therapeutic assets and technologies. They leverage their venture creation experience to translate and de-risk scientific innovation, advancing their investment portfolio and maximizing value for investors.

They support innovative early-stage companies with a mission to translate groundbreaking science into transformative therapies. They focus on private companies in the US and Europe as key innovation hubs, with the goal of identifying global technological leaders regardless of their location.

Mostly dedicated to seed and early stage funding, Theodorus invests in Biotech, MedTech, Digital and Engineering applications. Theodorus has a priority access to ULB R&D outcome and spin-offs, but can also invest in projects outside ULB. The investment size varies from 250k€ (first investment) to 2.5M€ per company.

VIVES is a seed capital fund initiated by UCLouvain which invests in companies developing disruptive innovations with a positive societal impact. For more than 15 years, VIVES has invested in companies active in all technological sectors.

They are a life sciences venture capital fund that helps transform scientific innovation into products that positively impact people’s lives. Their extensive network and expertise in the sector allow them to contribute more than just capital. They aim to be part of the DNA of the new ventures they back.